Company / Assets per Share
Monopar Therapeutics Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$23.06
FY2025
5-year range
$0.57 / $23.06
FY2021-FY2025
Trend
+14.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.57 to $23.06 over the past 2 years.
Based on SEC 10-K filings.
23.06 in FY2025.
Improved from $0.57 to $23.06 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 14.0% year-over-year.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 19.82 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.06 | +14.0% |
| FY2024 | $20.23 | +3465.0% |
| FY2023 | $0.57 | -60.5% |
| FY2019 | $1.44 | +82.5% |
| FY2018 | $0.79 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026